d operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares d with three other
companies in this sector in CHINA :
Shanghai Runda Medical Technology Co Ltd
sales of 7.05 billion Chinese Renmimbi [US$1.04 billion]
of which 96%
Zhejiang Medicine Co., Ltd.
(7.04 billion Chinese Renmimbi [US$1.04 billion]
of which 74%
was Domestic), and
KPC Pharmaceuticals Inc
(8.10 billion Chinese Renmimbi [US$1.20 billion]
of which 44%
was Drugs Wholesale and Retail).
Sales increased substantially in 2019:
d reported sales of 7.59 billion Chinese Renmimbi (US$1.12 billion)
December of 2019.
increase of 711.2%
versus 2018, when the company's sales were 935.45 million Chinese Renmimbi.
Sales at d have increased during each of the previous five years
(and since 2014, sales have increased a total of 1,312%).